Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Hisse Senetlerindeki Sıralama #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Hisse Fiyatı
$9.60
Son senkronizasyon: 2025-05-21
Piyasa Değeri
$1.08B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret OptiNose, Inc. (OPTN)

Kategori

OptiNose, Inc. (OPTN) için gelir
Mar 2025 itibarıyla gelir TTM: $81.86M
OptiNose, Inc. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $81.86M'dir. 2023 yılında şirketin geliri $70.99M önceki yıla göre azalma 2022 yılındaki $76.28M gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
OptiNose, Inc. için 2015 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $81.86M 4.64%
2024 $78.23M 10.20%
2023 $70.99M -6.93%
2022 $76.28M 2.18%
2021 $74.65M 51.99%
2020 $49.12M 41.83%
2019 $34.63M 390.18%
2018 $7.07M 0.00%
2017 0.00 -100.00%
2016 $47.50M 55,782.35%
2015 $85.00K 0.00%
Benzer şirketler veya rakiplerin geliri